Yijiao (Joanna) Wang, S. Kulasegaran, S. Srinivasa, J. Koea, A. MacCormick
{"title":"32. QUALITY PERFORMANCE INDICATOR COMPLIANCE FOR THE TREATMENT OF OESOPHAGEAL ADENOCARCINOMA IN NEW ZEALAND","authors":"Yijiao (Joanna) Wang, S. Kulasegaran, S. Srinivasa, J. Koea, A. MacCormick","doi":"10.1093/dote/doad052.012","DOIUrl":null,"url":null,"abstract":"\n \n \n Oesophageal adenocarcinoma (OAC) is a lethal condition. The management is typically multifaceted with oesophagectomy being the cornerstone of treatment. Quality performance indicators (QPIs) are objective measurements of aspects of patient’s care that affect clinical outcomes. We look to measure a set of clinically relevant QPIs that can be used to capture key aspects of patient management at our institution.\n \n \n \n all patients with OAC treated from 2010 to 2015, and 2020 to 2021 at Te Whatu Ora Waitemata were included. Patients with secondary metastases to the oesophagus or gastric cancer with extension to the oesophagus were excluded. Electronic data in the form of clinic letters, operation notes, histology and radiology reports were reviewed. QPI adherence was collected in binary form.\n \n \n \n QPIs with consistently high compliance rates include radiological staging and histological diagnosis, perioperative dietitian involvement, explanations of disease and treatment intent, and pathology report documentation. QPIs demonstrating significant change and improvement across the two groups include endoscopic resection (60.0% of patients with T1 disease in 2010 to 88.9% in 2020 group), multimodality treatment (majority ECF and ECX perioperative chemotherapy in 2010 to majority FLOT chemotherapy in 2020 group) and minimally invasive approach (30.4% hybrid in 2010 compared to 72.4% hybrid in 2020).\n \n \n \n QPIs from the systematic review were readily measurable and were variably implemented in clinical practice. Areas requiring improvement were identified however relevance to real-world clinical outcomes require further focus of investigation.\n","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/dote/doad052.012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Oesophageal adenocarcinoma (OAC) is a lethal condition. The management is typically multifaceted with oesophagectomy being the cornerstone of treatment. Quality performance indicators (QPIs) are objective measurements of aspects of patient’s care that affect clinical outcomes. We look to measure a set of clinically relevant QPIs that can be used to capture key aspects of patient management at our institution.
all patients with OAC treated from 2010 to 2015, and 2020 to 2021 at Te Whatu Ora Waitemata were included. Patients with secondary metastases to the oesophagus or gastric cancer with extension to the oesophagus were excluded. Electronic data in the form of clinic letters, operation notes, histology and radiology reports were reviewed. QPI adherence was collected in binary form.
QPIs with consistently high compliance rates include radiological staging and histological diagnosis, perioperative dietitian involvement, explanations of disease and treatment intent, and pathology report documentation. QPIs demonstrating significant change and improvement across the two groups include endoscopic resection (60.0% of patients with T1 disease in 2010 to 88.9% in 2020 group), multimodality treatment (majority ECF and ECX perioperative chemotherapy in 2010 to majority FLOT chemotherapy in 2020 group) and minimally invasive approach (30.4% hybrid in 2010 compared to 72.4% hybrid in 2020).
QPIs from the systematic review were readily measurable and were variably implemented in clinical practice. Areas requiring improvement were identified however relevance to real-world clinical outcomes require further focus of investigation.
食管腺癌(OAC)是一种致死性疾病。治疗通常是多方面的,食道切除术是治疗的基石。质量绩效指标(QPI)是对影响临床结果的患者护理方面的客观测量。我们希望测量一组临床相关的QPI,这些QPI可用于捕捉我们机构患者管理的关键方面。包括2010年至2015年和2020年至2021年在Te Whatu Ora Waitemata接受治疗的所有OAC患者。食管继发性转移或癌症延伸至食管的患者被排除在外。对临床信函、手术记录、组织学和放射学报告等形式的电子数据进行了审查。QPI依从性以二元形式收集。一贯高依从性的QPI包括放射学分期和组织学诊断、围手术期营养师参与、疾病和治疗意图的解释以及病理学报告文件。两组的QPI显示出显著的变化和改善,包括内镜切除术(2010年T1疾病患者的比例为60.0%,2020年为88.9%)、多模式治疗(2010年多数为ECF和ECX围手术期化疗,2020年多数为FLOT化疗)和微创方法(2010年30.4%为混合,2020年72.4%为混合)。系统综述中的QPI易于测量,在临床实践中也有不同的实施方式。确定了需要改进的领域,但与现实世界临床结果的相关性需要进一步关注调查。